Advisors Preferred LLC Purchases Shares of 26,504 Concentrix Corporation $CNXC

Advisors Preferred LLC bought a new position in shares of Concentrix Corporation (NASDAQ:CNXC) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 26,504 shares of the company’s stock, valued at approximately $725,000.

A number of other hedge funds have also added to or reduced their stakes in CNXC. Royal Bank of Canada boosted its position in shares of Concentrix by 9.5% during the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock worth $2,643,000 after purchasing an additional 4,133 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Concentrix by 75.1% in the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock worth $23,552,000 after acquiring an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Concentrix by 17.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after acquiring an additional 21,746 shares during the period. Focus Partners Wealth acquired a new stake in Concentrix in the first quarter valued at approximately $781,000. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares in the last quarter. 90.34% of the stock is currently owned by institutional investors.

Concentrix Stock Down 5.3%

Shares of NASDAQ:CNXC opened at $23.57 on Wednesday. The business’s 50 day moving average is $25.03 and its 200 day moving average is $30.76. Concentrix Corporation has a 12-month low of $19.12 and a 12-month high of $62.14. The stock has a market cap of $1.44 billion, a price-to-earnings ratio of -1.11, a PEG ratio of 0.46 and a beta of 0.47. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.46.

Concentrix (NASDAQ:CNXC) last released its quarterly earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The company had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the previous year, the company posted $2.70 earnings per share. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, sell-side analysts forecast that Concentrix Corporation will post 9.67 earnings per share for the current fiscal year.

Concentrix Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th will be issued a $0.36 dividend. The ex-dividend date is Friday, July 24th. This represents a $1.44 annualized dividend and a dividend yield of 6.1%. Concentrix’s dividend payout ratio is currently -6.75%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CNXC. Zacks Research lowered Concentrix from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 2nd. Bank of America decreased their price target on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research note on Tuesday, June 30th. Robert W. Baird lowered their price objective on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a report on Tuesday, June 30th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Finally, Barrington Research reduced their price objective on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $32.75.

Insider Buying and Selling at Concentrix

In related news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the business’s stock in a transaction dated Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the transaction, the insider directly owned 2,773,667 shares in the company, valued at approximately $61,714,090.75. The trade was a 68.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.90% of the stock is owned by insiders.

Concentrix Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology?driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back?office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.